Basis of Carcinogenesis

  • Anne E. MurphyEmail author
  • Françoise Charnay-Sonnek
Part of the Principles of Specialty Nursing book series (PSN)


We can define cancer as a genetic, multistep, and clonal disease, but we will see later in this chapter that this perspective is changing.

This chapter is dedicated to normal cell biology and how cells become malignant.


Genome Genotype Phenotype Telomerase Hallmarks of cancer Tumor cell environement Angiogenesis Immune process 


  1. 1.
    Halsey Lea D, Jenkins JF, Francomano CA. “Genetics in clinical practice”, new directions for nursing and health care. Sudbury: Jones & Bartlett Publishers, Inc; 1998.Google Scholar
  2. 2.
  3. 3.
    Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.CrossRefGoogle Scholar
  4. 4.
    Trahan Rieger P. Biotherapy, a comprehensive overview. 2nd ed. Sudbury: Jones & Bartlett Publ Inc; 2001.Google Scholar
  5. 5.
    Chial H. Proto-oncogenes to oncogenes to cancer. Nat Educ. 2008;1(1):33. Write Science Right @2008 Nature Education.Google Scholar
  6. 6.
    Mooney SM, Jolly MK, Levine H, Kulkarni P. Phenotypic plasticity in prostate cancer: role of intrinsically disordered proteins. Asian J Androl. 2016;18:704–710. © 2016 AJA, SIMM & SJTU. All rights reserved 1008-682X.Google Scholar
  7. 7.
    Kim YA, Cho DY, Przytycka TM. Understanding genotype-phenotype effects in cancer via network approaches. PLoS Comput Biol. 2016; Scholar
  8. 8.
    Levine AJ, Puzio-Kuter AM. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science. 2010;330:1340.CrossRefGoogle Scholar
  9. 9.
    Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70.CrossRefGoogle Scholar
  10. 10.
    Li H, Fan X, Houghton JM. Tumor Microenvironment: The Role of the Tumor Stroma in Cancer. J Cell Biochem. 2007;101:805–15.CrossRefGoogle Scholar
  11. 11.
    Bocci G, Lenzi P. Looking for the word “angiogenesis” in the history of health sciences: from ancient times to the first decades of the twentieth century. World J Surg. 2016;41:1625–34.Google Scholar
  12. 12.
    Bracci L, Mandarini E, Brunetti J, Depau L, Pini A, Terzuoli L, Scali S, Falciani C. The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells. PLoS One. 2018; Scholar
  13. 13.
    Palucka AK, Coussens LM. The basis of oncoimmunology. Cell. 2016;164(6):1233–47. Scholar
  14. 14.
    Maciver NJ, Jacobs SR, Wieman HL, Wofford JA, Hayes HL, Rathmell JC. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukoc Biol. 2008;84:949–57.CrossRefGoogle Scholar
  15. 15.
    Chikuma S, Kanamori M, Mise-Omata S, Yoshimura A. Suppressors of cytokine signaling: potential immune checkpoint molecules for cancer immunotherapy. Cancer Sci. 2017;108:574–80.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.University Hospital of GenevaGenevaSwitzerland
  2. 2.UnicancerParisFrance

Personalised recommendations